Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BIOTECH & TECHNOLOGY INVESTING *UNDERVALUED*{T/A F/A & V} -- Ignore unavailable to you. Want to Upgrade?

To: BRAVEHEART who wrote (347)	4/6/2000 11:56:00 AM
From: tuck	Read Replies (2) \| Respond to of 423

Jeffrey, Some news from DSCuM: businesswire.com siliconinvestor.com Maybe there's still hope. Doing quick trades on first and second tier names. ABSC, AMGN, WCOM, LU, & NGEN working well. Eases the LOR/DSCM/PCTH pain a bit. UROG seems to be holding quite well at the price of Paramount's last private placement. Should round 2 of the Biotech BloodBath come to pass, I will buy that one. Seems to me the NAZ has more support at ~3700 than at 3300, and indeed, it held its first test of that level. Should it test again and fail, I think it might go a bit further, say to ~3000 flat. Getting my funds ready. Cheers, Tuck